Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.
暂无分享,去创建一个
[1] J. Vervoort,et al. Peroxidase-catalyzed formation of quercetin quinone methide-glutathione adducts. , 2000, Archives of biochemistry and biophysics.
[2] E. Andrès,et al. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis , 2008, Expert opinion on drug safety.
[3] Vladimir Poroikov,et al. SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds , 2015, Bioinform..
[4] Kristin P. Bennett,et al. RS-Predictor: A New Tool for Predicting Sites of Cytochrome P450-Mediated Metabolism Applied to CYP 3A4 , 2011, J. Chem. Inf. Model..
[5] J. Bauman,et al. Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug , 2008, Drug Metabolism and Disposition.
[6] David E. Gloriam,et al. The SMARTCyp cytochrome P450 metabolism prediction server , 2010, Bioinform..
[7] B. K. Park,et al. The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine. , 1994, Journal of medicinal chemistry.
[8] M. Meyer,et al. Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. , 2010, Journal of mass spectrometry : JMS.
[9] Alessandro Pedretti,et al. Reactions and enzymes in the metabolism of drugs and other xenobiotics. , 2012, Drug discovery today.
[10] Sanjay Joshua Swamidass,et al. XenoSite server: a web-available site of metabolism prediction tool , 2015, Bioinform..
[11] D. Ross,et al. Generation of reactive species and fate of thiols during peroxidase-catalyzed metabolic activation of aromatic amines and phenols. , 1985, Environmental health perspectives.
[12] J. Uetrecht,et al. Animal models of idiosyncratic drug reactions. , 2004, Chemico-biological interactions.
[13] W. Lutz,et al. In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. , 1979, Mutation research.
[14] W. Humphreys,et al. Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry. , 2007, Chemical research in toxicology.
[15] Kristin P. Bennett,et al. RS-Predictor Models Augmented with SMARTCyp Reactivities: Robust Metabolic Regioselectivity Predictions for Nine CYP Isozymes , 2012, J. Chem. Inf. Model..
[16] Novel Bioactivation Mechanism of Reactive Metabolite Formation from Phenyl Methyl-Isoxazoles , 2012, Drug Metabolism and Disposition.
[17] Vijay T. Ahuja,et al. Identification and mitigation of a reactive metabolite liability associated with aminoimidazoles. , 2014, Chemical research in toxicology.
[18] A. Breckenridge,et al. Drug-protein conjugates--XVIII. Detection of antibodies towards the antimalarial amodiaquine and its quinone imine metabolite in man and the rat. , 1989, Biochemical pharmacology.
[19] A. Wertheimer,et al. Withdrawing Drugs in the U.S. Versus Other Countries , 2012 .
[20] Sanjay Joshua Swamidass,et al. A simple model predicts UGT-mediated metabolism , 2016, Bioinform..
[21] C. Hasegawa,et al. Structure–activity relationships of 2α-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[22] Vaibhav A. Dixit,et al. Advances in Computational Prediction of Regioselective and Isoform‐Specific Drug Metabolism Catalyzed by CYP450s. , 2016 .
[23] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[24] S. Knowles,et al. Idiosyncratic drug reactions: the reactive metabolite syndromes , 2000, The Lancet.
[25] T. Baillie,et al. In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations , 2008, Drug Metabolism And Disposition.
[26] S. Parapini,et al. Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine. , 2009, Journal of medicinal chemistry.
[27] Sanjay Joshua Swamidass,et al. RS-WebPredictor: a server for predicting CYP-mediated sites of metabolism on drug-like molecules , 2013, Bioinform..
[28] D. Dalvie,et al. Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts. , 2009, Chemical research in toxicology.
[29] Sanjay Joshua Swamidass,et al. Extending P450 site-of-metabolism models with region-resolution data , 2015, Bioinform..
[30] T. Schultz,et al. Verification of the structural alerts for Michael acceptors. , 2007, Chemical research in toxicology.
[31] David E. Gloriam,et al. SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism. , 2010, ACS medicinal chemistry letters.
[32] J. Palmblad,et al. Drug-induced neutropenia--a survey for Stockholm 1973-1978. , 2009, Acta medica Scandinavica.
[33] T. Monks,et al. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. , 2002, Current drug metabolism.
[34] William M. Lee,et al. Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.
[35] T. Surmann,et al. [Cholestatic jaundice during flecainide therapy]. , 1984, Deutsche medizinische Wochenschrift.
[36] A. Y. Lu,et al. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[37] David Basketter,et al. The chemistry of contact allergy: why is a molecule allergenic? , 1995, Contact dermatitis.
[38] Chris Morley,et al. Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit , 2008, Chemistry Central journal.
[39] J. Mckim. Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance , 2010, Combinatorial chemistry & high throughput screening.
[40] J. Singer,et al. The Novel Anthracenedione, Pixantrone, Lacks Redox Activity and Inhibits Doxorubicinol Formation in Human Myocardium: Insight to Explain the Cardiac Safety of Pixantrone in Doxorubicin-Treated Patients , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[41] R. Boulieu,et al. High-performance liquid chromatographic assay to detect hydroxylate and conjugate metabolites of propofol in human urine. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[42] M. Stephens. The Dawn of Drug Safety , 2010 .
[43] F. Guengerich,et al. Mechanisms of drug toxicity and relevance to pharmaceutical development. , 2011, Drug metabolism and pharmacokinetics.
[44] H. Nelis,et al. Evidence for metabolic inertness of doxycycline. , 1981, Journal of pharmaceutical sciences.
[45] J. Johnson,et al. Biotransformation and elimination of 14C-flecainide acetate in humans. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[46] B. K. Park,et al. Immune pathomechanism of drug hypersensitivity reactions. , 2011, The Journal of allergy and clinical immunology.
[47] Paolo Benedetti,et al. Exposition and reactivity optimization to predict sites of metabolism in chemicals. , 2013, Drug discovery today. Technologies.
[48] James J. P. Stewart,et al. MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..
[49] Sanjay Joshua Swamidass,et al. XenoSite: Accurately Predicting CYP-Mediated Sites of Metabolism with Neural Networks , 2013, J. Chem. Inf. Model..
[50] Deepak Dalvie,et al. Predicting toxicities of reactive metabolite-positive drug candidates. , 2015, Annual review of pharmacology and toxicology.
[51] F. Lombardo,et al. BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONE-IMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4 , 2005, Drug Metabolism and Disposition.
[52] Pierre Baldi,et al. A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval , 2010, Bioinform..
[53] J. Schwöbel,et al. Prediction of michael-type acceptor reactivity toward glutathione. , 2010, Chemical research in toxicology.
[54] H. Gelboin. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. , 1980, Physiological reviews.
[55] G M Cohen,et al. Quinone chemistry and toxicity. , 1992, Toxicology and applied pharmacology.
[56] Lucija Peterlin Mašič,et al. Bioactivation potential of thiophene-containing drugs. , 2014, Chemical research in toxicology.
[57] J. Bolton,et al. Oxidation of raloxifene to quinoids: potential toxic pathways via a diquinone methide and o-quinones. , 2004, Chemical research in toxicology.
[58] G. Williamson,et al. The C-glycosyl flavonoid, aspalathin, is absorbed, methylated and glucuronidated intact in humans. , 2009, Molecular nutrition & food research.
[59] S. Joshua Swamidass,et al. Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network , 2016, ACS central science.
[60] Lars Olsen,et al. Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms , 2012, ChemMedChem.
[61] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[62] P. Moldéus,et al. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. , 1985, Molecular pharmacology.
[63] K. Midha,et al. Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.
[64] W. M. Lee,et al. Drug-induced hepatotoxicity. , 1995, The New England journal of medicine.
[65] Mingshe Zhu,et al. Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering. , 2007, Analytical chemistry.
[66] Dominic P. Williams,et al. The Generation, Detection, and Effects of Reactive Drug Metabolites , 2013, Medicinal research reviews.
[67] Yuan Chen,et al. Metabolic Activation of Nevirapine in Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4 , 2009, Drug Metabolism and Disposition.
[68] P. Anzenbacher,et al. Cytochromes P450 and metabolism of xenobiotics , 2001, Cellular and Molecular Life Sciences CMLS.
[69] Valérie Campagna-Slater,et al. Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s , 2012, J. Chem. Inf. Model..
[70] D. Lamb,et al. Streptomyces cytochromes P450: applications in drug metabolism , 2013, Expert opinion on drug metabolism & toxicology.
[71] Gabriele Cruciani,et al. Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. , 2003, Journal of medicinal chemistry.
[72] B. Meunier,et al. Peroxidase-catalyzed O-demethylation reactions. Quinone-imine formation from 9-methoxyellipticine derivatives. , 1985, The Journal of biological chemistry.
[73] Chang-Joon Lee,et al. EaMEAD: Activation Energy Prediction of Cytochrome P450 Mediated Metabolism with Effective Atomic Descriptors , 2009, J. Chem. Inf. Model..
[74] Jerome P. Charba,et al. Skill in Precipitation Forecasting in the National Weather Service , 1980 .
[75] Mehryar Mohri,et al. Confidence Intervals for the Area Under the ROC Curve , 2004, NIPS.
[76] Katie Chan,et al. Structure–activity relationships for thiol reactivity and rat or human hepatocyte toxicity induced by substituted p‐benzoquinone compounds , 2008, Journal of applied toxicology : JAT.
[77] A. Stepan,et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. , 2011, Chemical research in toxicology.
[78] Pavel Hobza,et al. On the performance of the semiempirical quantum mechanical PM6 and PM7 methods for noncovalent interactions , 2013 .
[79] N. Kitteringham,et al. Drug-protein conjugates--XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man. , 1988, Biochemical pharmacology.
[80] Michael M. Mysinger,et al. Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[81] D. Adams,et al. Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.
[82] S. Joshua Swamidass,et al. Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione. , 2015, Chemical research in toxicology.
[83] M. Mahajan,et al. In Vitro Metabolism of Oxymetazoline: Evidence for Bioactivation to a Reactive Metabolite , 2011, Drug Metabolism and Disposition.
[84] M. Kubo,et al. Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity1 , 2007, The Journal of Immunology.
[85] B. Wen,et al. Metabolic activation of the phenothiazine antipsychotics chlorpromazine and thioridazine to electrophilic iminoquinone species in human liver microsomes and recombinant P450s. , 2009, Chemico-biological interactions.
[86] M. Numazawa,et al. Biological aromatization of Δ4,6- and Δ1,4,6-androgens and their 6-alkyl analogs, potent inhibitors of aromatase , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[87] E. Cavalieri,et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[88] M. Cameron,et al. Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways , 2009, Drug Metabolism and Disposition.
[89] S. Joshua Swamidass,et al. Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network , 2015, ACS central science.
[90] Sanjay Joshua Swamidass,et al. Improved Prediction of CYP-Mediated Metabolism with Chemical Fingerprints , 2015, J. Chem. Inf. Model..
[91] F. Guengerich,et al. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.
[92] P. Nguyen-Dinh,et al. Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. , 1985, Life sciences.
[93] H. Orhan. Extrahepatic targets and cellular reactivity of drug metabolites. , 2014, Current medicinal chemistry.
[94] J. Uetrecht,et al. Bioactivation of Nevirapine to a Reactive Quinone Methide: Implications for Liver Injury , 2012, Chemical research in toxicology.
[95] M. Lindquist,et al. Quality criteria for early signals of possible adverse drug reactions , 1990, The Lancet.